YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Enbrel
FDA Releases More Humira, Enbrel, Remicade Info
Sep 1, 2009 | Parker Waichman Alonso LLP
Federal regulators have released more information regarding cancers associated with drugs like Humira, Enbrel, and Remicade. Last month,...
Group Calls For Study Of Arthritis Drugs
Jul 1, 2009 | Parker Waichman Alonso LLP
Arthritis and other autoimmune medications have made recent headlines over a variety of issues including links to serious opportunistic fungal...
Simponi Carries Risk of Possibly Fatal Fungal Infections
May 29, 2009 | Parker Waichman Alonso LLP
Simponi, a new rheumatoid arthritis drug, can cause severe and potentially fatal fungal infections, according to a new warning released yesterday by...
Humira, Cimzia, Enbrel and Remicade to Bear Stronger Infection Warnings
Sep 4, 2008 | Parker Waichman Alonso LLP
Federal regulators have ordered the makers of Humira, Cimzia, Enbrel, and Remicade to strengthen the existing warnings about opportunistic fungal...
Despite Enbrel Risks, FDA Panel Recommends it for Psoriasis in Children
Jun 19, 2008 | Parker Waichman Alonso LLP
A Food & Drug Administration (FDA) advisory panel has recommended that the agency approve Enbrel to treat moderate-to-severe psoriasis in...
Enbrel Infection Risk Cited
Jun 16, 2008 | Parker Waichman Alonso LLP
Enbrel has been linked to sometimes deadly infections when administered to children, casting doubts that the Food & Drug Administration (FDA)...
Humira, Enbrel, Remicade Being Investigated for Cancer Link
Jun 4, 2008 | Parker Waichman Alonso LLP
Humira and other drugs used to treat autoimmune disorders are being investigated by federal regulators amid concern that they might be linked to...
Enbrel Black Box Warns of Tuberculosis Risk
May 1, 2008 | Parker Waichman Alonso LLP
Enbrel, a drug used to treat psoriasis that has been associated with serious infections, including tuberculosis in some patients. Enbrel's...
More Trouble for Amgen, as Enbrel Gets Stronger Infection Warnings
Mar 18, 2008 | Parker Waichman Alonso LLP
Enbrel, a popular treatment for rheumatoid arthritis and psoriasis, is getting stronger warnings about serious infections associated with its...
Enbrel Marketing Focus of New Jersey Amgen Probe
Jan 18, 2008 | Parker Waichman Alonso LLP
The marketing of Enbrel is the now the subject of an investigation by the New Jersey Attorney General’s Office. The Enbrel probe...
Enbrel
